TITLE

INSULIN GLARGINE IN GASTROSTOMY FEEDING

AUTHOR(S)
Isildak, S. M.; Ayturk, S.; Bascil, S.; Tutuncu, N. B.
PUB. DATE
April 2012
SOURCE
Acta Endocrinologica (1841-0987);Apr-Jun2012, Vol. 8 Issue 2, p257
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Context. For control of blood glucose in diabetic patients on enteral feeding either insulin infusion or multiple insulin injections are used. However, both of these methods necessitate a very close follow-up and are not easy to apply during home care. Objective. In this study we aimed to see whether insulin glargine once daily is proper for glucose regulation in enterally fed diabetic patients. DESIGN: Insulin glargine is given to enterally fed diabetic patients and they are followed up for three months. Subjects and methods. Thirteen diabetic stroke patients with PEG are involved in the study. Treatment of these patients is switched from insulin infusion or multiple insulin injections to once daily insulin glargine and they are followed up for 3 months. Results. Mean blood glucose values are improved with once daily insulin glargine regimen. HbA1c decreased from 7.2% ± 1.5 5. to 6.7% ± 0.8 with insulin glargine. Daily insulin requirement of the patients is significantly decreased as well. A significant decrease in the hypoglycemic episodes is detected with glargine (p<0,0001). Conclusion. Insulin glargine once daily is a safe and effective regimen for diabetic patients with PEG.
ACCESSION #
77415691

 

Related Articles

  • EVALUATION OF ANTI-DIABETIC POTENTIALS OF METHANOLIC EXTRACT OF FICUS MICROCARPA LEAVES IN ALLOXAN INDUCED DIABETIC RATS. RAVICHANDRA, V. D.; PAARAKH, PADMAA M. // International Journal of Pharmacy & Pharmaceutical Sciences;2013 Supplement, Vol. 5 Issue Supp 3, p369 

    Objective: The present study was designed to evaluate the acute and chronic effects of the extract against alloxan induced diabetic rats. Methods: In acute study, hypoglycemic potency of methanolic extract of Ficus microcarpa was assessed by oral glucose tolerance test (OGTT) and in chronic...

  • Your Insulin Therapy.  // American Family Physician;8/1/2004, Vol. 70 Issue 3, p511 

    Presents information on insulin therapy. Kinds of insulin; Symptoms of low blood sugar; Mealtime insulin type and dose.

  • Cdk5-dependent regulation of glucose-stimulated insulin secretion. Fan-Yan Wei; Nagashima, Kazuaki; Ohshima, Toshio; Saheki, Yasunori; Yun-Fei Lu; Matsushita, Masayuki; Yamada, Yuichiro; Mikoshiba, Katsuhiko; Seino, Yutaka; Matsui, Hideki; Tomizawa, Kazuhito // Nature Medicine;Oct2005, Vol. 11 Issue 10, p1104 

    Tight glycemic control in individuals with diabetes mellitus is essential to prevent or delay its complications. Present treatments to reduce hyperglycemia mainly target the ATP-sensitive K+ (KATP) channel of pancreatic beta cells to increase insulin secretion. These current approaches are often...

  • Improved Insulin Sensitivity by GLUT12 Overexpression in Mice. Purcell, Scott H.; Aerni-Flessner, Lauren B.; Willcockson, Alexandra R.; Diggs-Andrews, Kelly A.; Fisher, Simon J.; Moley, Kelle H. // Diabetes;May2011, Vol. 60 Issue 5, p1478 

    OBJECTIVE--Evidence suggests that insulin-sensitive glucose transporters (GLUTs) other than GLUT4 may exist. To investigate whether GLUT12 may represent another insulin-sensitive GLUT, transgenic (TG) mice that overexpress GLUT12 were characterized. RESEARCH DESIGN AND METHODS--TG mice that...

  • Low-dose guar improves diabetic control. Jones, D. B.; Lousley, S.; Jelfs, R.; Slaughter, P.; Carter, R. D.; Mann, J. I. // Journal of the Royal Society of Medicine;Jul1985, Vol. 78 Issue 7, p546 

    Twenty diabetic outpatients (12 non-insulin-treated and 8 insulin-treated) were given guar granulate in a dose of 10 g daily for two months in order to study the effect on glycaemic control and lipid levels. Mean glycosylated haemoglobin levels (HbA1c%) fell from 1.1± 2.0% pre-guar to 10.5...

  • 5-Aminoimidazole-4-Carboxamide-1-β-D-Ribofuranoside Causes Acute Hepatic Insulin Resistance In Vivo. Pencek, R. Richard; Shearer, Jane; Camacho, Raul C.; James, Freyja D.; Lacy, D. Brooks; Fueger, Patrick T.; Donahue, E. Patrick; Snead, Wanda; Wasserman, David H. // Diabetes;Feb2005, Vol. 54 Issue 2, p355 

    The infusion of 5-aminoimidazole-4-carboxamide-1-β-D-ribofuranoside (AICAR) causes a rise in tissue concentrations of the AMP analog 5-aminoimidazole-4-carboxamide-1-β-D-ribofuranotide (ZMP), which mimics an elevation of cellular AMP levels. The purpose of this work was to determine the...

  • Lower Within-Subject Variability of Insulin Detemir in Comparison to NPH Insulin and Insulin Glargine in People With Type 1 Diabetes. Heise, Tim; Nosek, Leszek; Rønn, Birgitte Biilmann; Endahl, Lars; Heinemann, Lutz; Kapitza, Christoph; Draeger, Eberhard // Diabetes;Jun2004, Vol. 53 Issue 6, p1614 

    The aim of this randomized double-blind study was to compare the within-subject variability of the glucoselowering effect of a novel insulin analog, insulin detemir, with that of insulin glargine and NPH insulin in people with type 1 diabetes. Fifty-four subjects (32 males and 22 females, age 38...

  • Glucose monitoring.  // RN;Nov2004, Vol. 67 Issue 11, p4 

    Presents a guide for glucose monitoring. Newer types of blood glucose meter; Adjustments that can be made on insulin dosage; Ways of monitoring carbohydrate intake.

  • 2,3,7,8-Tetrachlorodibenzo-p-Dioxin (TCDD) and 1,2,3,4,7,8-Hexachlorodibenzo-p-Dioxin (HxCDD) Alter Body Weight by Decreasing Insulin-Like Growth Factor I (IGF-I) Signaling. Croutch, Claire R.; Lebofsky, Margitta; Schramm, Karl-Werner; Terranova, Paul F.; Rozman, Karl K. // Toxicological Sciences;May2005, Vol. 85 Issue 1, p560 

    2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) affects glycemia due to reduced gluconeogenesis; when combined with a reduction in feed intake, this culminates in decreased body weight. We investigated the effects of steady-state levels of TCDD (loading dose rates of 0.0125, 0.05, 0.2, 0.8, and 3.2...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics